When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Rheumatoid arthritis

Evidence last reviewed: 21 Mar 2026
Topic last updated: 07 Jan 2025

Summary

Definition

Анамнез и осмотр

Ключевые диагностические факторы

  • active symmetric arthritis lasting >6 weeks
  • age 50 to 55 years
  • female sex
  • joint pain
  • joint swelling
Полная информация

Другие диагностические факторы

  • morning stiffness
  • swan neck deformity
  • Boutonniere deformity
  • ulnar deviation
  • rheumatoid nodules
  • vasculitic lesions
  • pleuritic chest pain
  • scleritis and/or uveitis
Полная информация

Факторы риска

  • genetic predisposition
  • smoking
  • overweight or obesity
  • infection
Полная информация

Диагностические исследования

Исследования, которые показаны в первую очередь

  • rheumatoid factor (RF)
  • anticyclic citrullinated peptide (anti-CCP) antibody
  • radiographs
  • ultrasonography
Полная информация

Исследования, проведение которых нужно рассмотреть

  • disease activity score(s)
  • MRI
Полная информация

Алгоритм лечения

Острый

mild disease activity at initial presentation: not pregnant or planning pregnancy

moderate-to-severe disease activity at initial presentation: not pregnant or planning pregnancy

pregnant or planning pregnancy

ПРОДОЛЖЕНИЕ

failure to reach low disease activity after 3 months of therapy: not pregnant or planning pregnancy

Составители

Авторы

Yusuf Yazici, MD
Yusuf Yazici

Clinical Associate Professor of Medicine

New York University School of Medicine

New York

NY

Раскрытие информации

YY receives research support from BMS and Amgen; he has consulted for Amgen, BMS, Hemay, Chugai, and Sanofi.

Рецензенты

Joshua F. Baker, MD, MSCE

Associate Professor of Medicine and Epidemiology

University of Pennsylvania

Pennsylvania

PA

Раскрытие информации

JFB has received consulting fees from Bristol-Myers Squibb, Pfizer, Cumberland Pharma, and CorEvitas.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Список литературы

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Основные статьи

Fraenkel L, Bathon JM, England BR, et al. 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 2021 Jul;73(7):1108-23.Полный текст  Аннотация

National Institute for Health and Care Excellence. Rheumatoid arthritis in adults: management. Oct 2020 [internet publication].Полный текст

Smolen JS, Landewé RBM, Bergstra SA, eta al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023 Jan;82(1):3-18 Epub 2022 Nov 10.Полный текст  Аннотация

Статьи, указанные как источники

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Rheumatoid arthritis images
  • Отличия

    • Psoriatic arthritis (PsA)
    • Infectious arthritis
    • Gout
    Больше Отличия
  • Guías de práctica clínica

    • 2023 American College of Rheumatology (ACR) guideline for the screening and monitoring of interstitial lung disease in people with systemic autoimmune rheumatic disease
    • Guideline for vaccinations in patients with rheumatic and musculoskeletal diseases
    Больше Guías de práctica clínica
  • Folletos para el paciente

    Rheumatoid arthritis

    Rheumatoid arthritis: questions to ask your doctor

    Más Folletos para el paciente
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad